Carnino L, Vetter P, Peyraud N, Aebischer-Perone S, Chappuis F, et al.
2021-06-15 • Journal of Travel Medicine
2021-06-15 • Journal of Travel Medicine
BACKGROUND AND RATIONALE Geneva University Hospitals were granted a temporary authorization to administer the recombinant live vesicular stomatitis virus rVSV-ZEBOV (Ervebo®) vaccine...
Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, et al.
2008-07-08 • PLOS Medicine
2008-07-08 • PLOS Medicine
BACKGROUND: The provision of highly active antiretroviral therapy (HAART) in resource-limited settings follows a public health approach, which is characterised by a limited number of reg...
Abbas M, Aloudat T, Bartolomei J, Carballo M, Durieux-Paillard S, et al.
2018-09-20 • Antimicrobial Resistance and Infection Control
2018-09-20 • Antimicrobial Resistance and Infection Control
The 2015-2017 global migratory crisis saw unprecedented numbers of people on the move and tremendous diversity in terms of age, gender and medical requirements. This article focuses on k...
2012-02-08 • International Journal of Tuberculosis and Lung Disease
2012-02-08 • International Journal of Tuberculosis and Lung Disease
BACKGROUND: Current treatment for drug-resistant tuberculosis (DR-TB) is inadequate, and outcomes are significantly poorer than for drug-susceptible TB, particularly for patients previou...
Davies A, Singh K, du Cros PAK, Mills EJ, Cooke GS, et al.
2013-02-05 • PLOS One
2013-02-05 • PLOS One
Co-infection with Hepatitis C (HCV) and HIV is common and HIV accelerates hepatic disease progression due to HCV. However, access to HCV treatment is limited and success rates are genera...
